icon-    folder.gif   Conference Reports for NATAP  
 
  (APASL) 25th Conference of the Asian Pacific
Association for the Study of the Liver
Feb 20-24 2016, Tokyo, Japan

Back grey_arrow_rt.gif
 
 
 
EQ-5D Results in Asian Patients with HCV Genotype 1b Receiving Daclatasvir plus Asunaprevir who are Interferon Intolerant/Ineligible
 
 
  Reported by Jules Levin
25th Conference of the Asian Pacific Association for the Study of the Liver (APASL 2016). Tokyo, Japan, February 2024, 2016
 
Gail Wygant,1 Ling Mo,2 Michelle Treitel,1 Rafia Bhore,1 Anne Torbeyns3
1Bristol-Myers Squibb Research and Development, Princeton, USA; 2Bristol-Myers Squibb, Shanghai, China; 3 Bristol-Myers Squibb, Braine-l'Alleud, Belgium

APASL1

APASL2

APASL3

APASL4

APASL5

APASL6

APASL7

APASL8

APASL9

APASL10

APASL11